Tue. 16 Apr 2024, 7:06am ET
Benzinga
Earnings, News
OptimizeRx (NASDAQ:OPRX) reported quarterly adjusted earnings of $0.26 per share which met the analyst consensus estimate. This is a 4 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $28.40 million which beat the analyst consensus estimate of $26.47 million by 7.29 percent. This is a 44.50 percent increase over sales of $19.65 million the same period last year.